当前位置：首页 > 文献互助 > 互助详情

Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment复制

用户TeLuikHvvMP8 1小时前 4 10 求助中 帖子自动结束时间: 2026-02-09 09:02:22

1. 文件大小不能超过300M, 允许上传文档或压缩包等

2. 请确保上传文献的真实性、完整性，不得对原文做任何修改

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1097/hep.0000000000001375复制

文献链接: https://journals.lww.com/10.1097/HEP.0000000000001375复制

其他信息:

出版社: Ovid Technologies (Wolters Kluwer Health)
作者: Beat Moeckli; Loyse Lanz; Manuel Rodríguez-Perálvarez; Stephanie Lacotte; Christian Toso

上一篇：Literacy and Illiteracy in Africa: The Tower of Babel Predicament

下一篇：Analyses of Recent Hit-Finding Campaigns for Difficult Targets Provides Guidance for Informed Integrated Hit Discovery

互助时间线

2026-02-04 09:02:22 [发起求助]

最新发布的求助

Bayesian Data Analysis 23分钟前
Palladium-Catalyzed Annulation of Aryl Heterocycles with Strained Alkenes 38分钟前
In vivo systemic evaluation of nasal drug absorption from powder formulations in rats 47分钟前
Reflections on Alnylam 48分钟前
Toward More Trustworthy QSAR: A Systematic Discussion on Data Set Partitioning 51分钟前
Efficacy and Safety of BI 1358894 in Patients With Borderline Personality Disorder 1小时前
Efficacy, Tolerability, and Safety of TRPC4/5 Inhibitor BI 1358894 in Patients With Major Depressive Disorder and Inadequate Response to Antidepressants 1小时前
Update on Alport syndrome: the report of the 2024 International Workshop on Alport syndrome 1小时前
Exploring the DS2 Scaffold for GABAA Receptor Modulation: Progress toward the Development of a GABAA δ-Subunit Preferring Negative Allosteric Modulator 1小时前
From Hit to Lead: Discovery of Novel Selective RIPK1 Inhibitor with Pyridoimidazole Scaffold for the Treatment of Autoimmune Diseases through Phenotypic Screening and Structural Optimization 1小时前
The Affinity Advantage 1小时前
Two Sides of the Same Coin: Transthyretin (TTR) as a Target or Drug Carrier for Drug (Bio)conjugates 1小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com